Keratin 8 and 18 Loss in Epithelial Cancer Cells Increases Collective Cell Migration and Cisplatin Sensitivity through Claudin1 Up-regulation

Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells

(2012) Julie Girouard et al.   GYNECOLOGIC ONCOLOGY

PKC and PKA Phosphorylation Affect the Subcellular Localization of Claudin-1 in Melanoma Cells

(2012) Amanda D. French et al.   International Journal of Medical Sciences

Keratins Mediate Localization of Hemidesmosomes and Repress Cell Motility

(2012) Kristin Seltmann et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Occludin is required for apoptosis when claudin–claudin interactions are disrupted

(2012) N Beeman et al.   Cell Death & Disease

Claudin-1 Up-regulates the Repressor ZEB-1 to Inhibit E-Cadherin Expression in Colon Cancer Cells

(2011) Amar B. Singh et al.   GASTROENTEROLOGY

Prostate Apoptosis Response 4 (Par-4), a Novel Substrate of Caspase-3 during Apoptosis Activation

(2011) P. Chaudhry et al.   MOLECULAR AND CELLULAR BIOLOGY

Functional ESCRT machinery is required for constitutive recycling of claudin-1 and maintenance of polarity in vertebrate epithelial cells

(2011) Joseph D. Dukes et al.   MOLECULAR BIOLOGY OF THE CELL

Interleukin 17A Promotes Hepatocellular Carcinoma Metastasis via NF-kB Induced Matrix Metalloproteinases 2 and 9 Expression

(2011) Jian Li et al.   PLoS One

PI(3)King Apart PTEN's Role in Cancer

(2010) S. Zhang et al.   CLINICAL CANCER RESEARCH

The Tight Junction Protein, Occludin, Regulates the Directional Migration of Epithelial Cells

(2010) Dan Du et al.   DEVELOPMENTAL CELL

Akt isoforms regulate intermediate filament protein levels in epithelial carcinoma cells

(2010) Anne-Marie Fortier et al.   FEBS LETTERS

Claudin 1 in Breast Tumorigenesis: Revelation of a Possible Novel “Claudin High” Subset of Breast Cancers

(2010) Yvonne Myal et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Protein Kinase C Activation Has Distinct Effects on the Localization, Phosphorylation and Detergent Solubility of the Claudin Protein Family in Tight and Leaky Epithelial Cells

(2010) Anita Sjö et al.   JOURNAL OF MEMBRANE BIOLOGY

Dynamics and functions of tight junctions

(2010) Emily Steed et al.   TRENDS IN CELL BIOLOGY

Collective invasion of carcinoma cells

(2010) Cedric Gaggioli   Cell Adhesion & Migration

Claudin Family of Proteins and Cancer: An Overview

(2010) Amar B. Singh et al.   Journal of Oncology

The Akt isoforms are present at distinct subcellular locations

(2009) Stacey A. Santi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Claudin-1 Acts through c-Abl-Protein Kinase Cδ (PKCδ) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver Cells

(2009) Chang-Hwan Yoon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Introducing intermediate filaments: from discovery to disease

(2009) John E. Eriksson et al.   JOURNAL OF CLINICAL INVESTIGATION

The basics of epithelial-mesenchymal transition

(2009) Raghu Kalluri et al.   JOURNAL OF CLINICAL INVESTIGATION

Collective cell migration in morphogenesis, regeneration and cancer

(2009) Peter Friedl et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells

(2009) G De Santis et al.   ONCOGENE

Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma

(2008) Patricia Pintor dos Reis et al.   CANCER

Cytokeratin 8 silencing in human nasopharyngeal carcinoma cells leads to cisplatin sensitization

(2008) Ying Wang et al.   CANCER LETTERS

The human keratins: biology and pathology

(2008) Roland Moll et al.   HISTOCHEMISTRY AND CELL BIOLOGY

NF-κB and epithelial to mesenchymal transition of cancer

(2008) Chengyin Min et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility

(2008) R. J. Paccione et al.   MOLECULAR CANCER THERAPEUTICS